Trident Lifeline Limited Share Price

Trident Lifeline Limited Share Price

BSE: 543616
|
Pharmaceuticals
|
S Cap
₹ 301.00
+₹3.65 (1.23%)
1D
Last updated 11 Sep, 2026, 15:22 IST

Trident Lifeline Limited Share Price Today

As of 15 Sep 2026, Trident Lifeline Limited share price is ₹301.00. The stock opened at ₹297.00, compared to its previous close of ₹297.35. During today's trading session, Trident Lifeline Limited share price moved in the range of ₹291.00 to ₹303.90, with an average price of ₹297.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹229.95 and a high of ₹328.00.

₹291.00
1.23% up today
₹303.90
1D LOW
1D HIGH

Trident Lifeline Limited Returns Calculator

Circuit
L
H
₹242.00
₹363.00
52-week
L
H
₹229.95
₹328.00

About Trident Lifeline Limited

Trident Lifeline Limited Share Price
ISIN
INE0MKA01014
Sector Market Cap
₹ 361.70 Cr

Trident Lifeline Limited (TLL) is an India-based medication provider. The Company produces and sells finished doses. Its geographical segment includes India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of the World. It discovered manufacturing formulations under its own brands alongside a loan license and a contract manufacturing model. It deals in capsules, tablets, liquid ointments, gels, ice gels, mouthwash, paste, solution, suspension, toothpaste, syrup, and cream. The product portfolio of the Company comprises a wide range of drugs like Anti-Bacterial, Anti-Diarrheal, Anti-Fungal, Anti-Malarial, Anti-Diabetic, Dental Cure, Pr, Multivitamin, Multimineral Nyteraceutoton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Anti-Lipidemic Drug, Anti-Parasiticical and Non-steroidal anti-inflammatory drugs (NSAIDS).

Trident Lifeline Limited Financial Highlights

  • Revenue: Trident Lifeline Limited reported revenue of ₹138.29 crore in FY26 vs ₹95.19 crore in FY25. It showed an increase of 45.28% on a yearly basis.
  • Operating Profit: Trident Lifeline Limited reported an operating profit of ₹27.19 crore in FY26 vs ₹13.61 crore in FY25. It showed an increase of 99.78% on a year-on-year basis.
  • Net Profit: Trident Lifeline Limited reported a net profit of ₹19.32 crore in FY26 vs ₹10.49 crore in FY25. It showed an increase of 84.18% on a yearly basis.

Trident Lifeline Limited Quarterly Result Highlights

  • Trident Lifeline Limited reported revenue of ₹34.29 crore in Jun 2026, compared with ₹51.57 crore in Mar 2026, representing a decrease of 33.51% on a quarter-on-quarter (QoQ) basis.
  • Trident Lifeline Limited reported an operating profit of ₹6.61 crore in Jun 2026, compared with ₹10.61 crore in Mar 2026, representing a decrease of 37.70% on a quarter-on-quarter (QoQ) basis.
  • Trident Lifeline Limited reported a profit of ₹5.07 crore in Jun 2026, compared with ₹6.80 crore in Mar 2026, reflecting a decrease of 25.44% on a QoQ basis.
  • The earnings per share (EPS) of Trident Lifeline Limited stood at ₹10.22 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
62.59%
FII
5.25%
Other DII
0.26%
Retail and other
31.90%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20257.71%
Dec 20257.04%
Mar 20267.24%
Jun 20265.25%
Mkt Cap Cr
361.70
P/E
16.74
P/B
3.58
ROE
18.97%
D/E
0.25
ROCE
18.05%
Div. Yield
0.00%
EPS(TTM)
15.50
Turnover
0.69
EV/EBITDA
10.78
Net Margin
0.00%
Op. Margin
0.00%
ROA
9.12%
Quick Ratio
0.00
Curr. Ratio
3.19
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Trident Lifeline outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Trident Lifeline appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Trident Lifeline earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Trident Lifeline Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹86.96₹44.63₹31.69₹21.77
Other Income₹8.23₹2.08₹1.16₹0.60
Total Revenue₹95.20₹46.71₹32.85₹22.37
Total Expenses₹81.58₹38.01₹26.27₹19.39
Profit Before Tax₹13.61₹8.70₹6.58₹2.98
Tax₹3.12₹2.76₹0.56-₹0.96
Profit After Tax₹10.49₹5.94₹6.02₹3.95
EPS - Basic₹10.22₹5.52₹6.22₹6.92
EPS - Diluted₹10.22₹5.52₹6.22₹6.92

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹13.61₹8.70₹6.58₹2.98
Income before WC changes₹20.47₹8.81₹6.66₹3.31
Change in Assets-₹27.26-₹9.86-₹25.73-₹2.91
Change in Liabilities₹2.44₹6.92₹1.21-₹0.82
Change in WC-₹24.82-₹2.94-₹24.52-₹3.72
Cash flow from Operations-₹10.24₹2.23-₹19.00-₹0.21
Cash flow from Investing-₹13.82-₹20.36-₹9.69-₹0.45
Cash flow from Financing₹19.76₹11.01₹42.28₹0.80
Total Cash Flow-₹4.31-₹7.13₹13.60₹0.14
Cash (Start of the year)₹6.65₹13.78₹0.18₹0.01
Cash (End of the year)₹2.46₹6.65₹13.78₹0.16

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹65.63₹35.10₹13.36₹3.17
Current Assets₹90.37₹51.97₹49.21₹10.67
Total Assets₹156.01₹87.08₹62.57₹13.83
Current Liabilities₹53.55₹20.26₹11.53₹7.57
Net Current Asset₹36.82₹31.72₹37.68₹3.10
Non-Current Liabilities₹32.80₹12.87₹3.93₹1.49
Equity Capital₹69.65₹53.95₹47.11₹4.78
Total Equity & Liabilities₹156.01₹87.08₹62.57₹13.83

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹67.80₹44.65₹31.69₹21.77
Other Income₹3.14₹2.20₹1.15₹0.60
Total Revenue₹70.94₹46.86₹32.85₹22.37
Total Expenses₹53.03₹37.06₹26.27₹19.39
Profit Before Tax₹17.91₹9.80₹6.57₹2.98
Tax₹4.85₹2.76₹0.56-₹0.96
Profit After Tax₹13.05₹7.04₹6.01₹3.95
EPS - Basic₹11.35₹6.13₹6.22₹6.92
EPS - Diluted₹11.35₹6.13₹6.22₹6.92

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹17.91₹9.80₹6.57₹2.98
Income before WC changes₹18.46₹9.27₹6.66₹3.31
Change in Assets-₹20.06-₹12.88-₹23.58-₹2.91
Change in Liabilities₹2.34₹6.88₹0.89-₹0.83
Change in WC-₹17.71-₹6.00-₹22.69-₹3.73
Cash flow from Operations-₹3.49₹0.90-₹16.60-₹0.19
Cash flow from Investing-₹7.88-₹11.01-₹5.56-₹0.50
Cash flow from Financing₹7.47₹2.35₹35.80₹0.80
Total Cash Flow-₹3.90-₹7.76₹13.64₹0.11
Cash (Start of the year)₹6.01₹13.77₹0.13₹0.01
Cash (End of the year)₹2.11₹6.01₹13.77₹0.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹28.65₹20.26₹8.64₹3.19
Current Assets₹69.14₹52.98₹47.86₹10.64
Total Assets₹97.79₹73.24₹56.50₹13.82
Current Liabilities₹25.14₹16.91₹10.34₹7.56
Net Current Asset₹44.00₹36.07₹37.52₹3.08
Non-Current Liabilities₹6.93₹3.65₹0.53₹1.49
Equity Capital₹65.73₹52.68₹45.63₹4.78
Total Equity & Liabilities₹97.79₹73.24₹56.50₹13.82
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
70.67
Bullish
ATR (14)
11.06
Neutral
STOCH(9,6)
85.53
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
38.21
Bearish
UO(9)
53.92
Neutral
ROC(12)
11.01
Bullish
WillR(14)
-12.81
Bearish
Period
Simple value
Exponential vaue
5D
294.54
294.9
10D
285.93
288.81
20D
281.06
281.79
50D
269.14
271.91
100D
260.65
267.7
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Trident Lifeline Limited Share Price
Trident Lifeline Limited
Pharmaceuticals
Add Stock
Add Another

Trident Lifeline Limited Share Price FAQs

Trident Lifeline Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837